COVID-19 Vaccination Rates and Factors Affecting Vaccine Hesitancy among Pregnant Women during the Pandemic Period in Turkey: A Single-Center Experience
Abstract
:1. Introduction
2. Materials and Methods
Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Ozisik, L.; Tanriover, M.D.; Rigby, S.; Ünal, S. European Federation of Internal Medicine ADVICE Working Group. ADVICE for a healthier life: Adult Vaccination Campaign in Europe. Eur. J. Intern. Med. 2016, 33, 14–20. [Google Scholar] [CrossRef] [PubMed]
- Freedman, M.S.; Ault, K.; Bernstein, H. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older—United States, 2021. MMWR Morb. Mortal. Wkly. Rep. 2021, 70, 193–196. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization Recommended Routine Immunization. 2015. Available online: http://www.who.int/immunization/policy/Immunization_routine_table1.pdf?ua=1 (accessed on 23 September 2022).
- Holstein, M.R.; Dawood, F.S.; O’Halloran, M.A.; Cummings, M.C.; Ujamaa, M.D.; Kirley, M.P.D.; Yousey-Hindes, M.K.; Fawcett, M.E.; Monroe, M.M.L.; Kim, M.S.; et al. Characteristics and Outcomes of Hospitalized Pregnant Women With Influenza, 2010 to 2019: A Repeated Cross-Sectional Study. Ann. Intern. Med. 2022, 175, 149–158. [Google Scholar] [CrossRef] [PubMed]
- Englund, J.A. The influence of maternal immunization on infant immune responses. J. Comp. Pathol. 2007, 137 (Suppl. 1), S16–S19. [Google Scholar] [CrossRef] [PubMed]
- COVID-19 Pandemic ‘Not Even Close to Being Over’, WHO Chief Warns. Available online: https://news.un.org/story/2020/06/1067342/ (accessed on 4 November 2022).
- WHO Coronavirus (COVID-19) Dashboard. Available online: https://covid19.who.int/ (accessed on 4 November 2022).
- COVID Data Tracker. Available online: https://covid.cdc.gov/covid-data-tracker/#datatracker-home (accessed on 4 November 2022).
- Allotey, J.; Stallings, E.; Bonet, M.; Yap, M.; Chatterjee, S.; Kew, T.; Debenham, L.; Llavall, A.C.; Dixit, A.; Zhou, D.; et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: Living systematic review and meta-analysis. BMJ 2020, 370, m3320. [Google Scholar] [CrossRef]
- Ko, J.Y.; DeSisto, C.L.; Simeone, R.M.; Ellington, S.; Galang, R.R.; Oduyebo, T.; Gilboa, S.M.; Lavery, A.M.; Gundlapalli, A.V.; Shapiro-Mendoza, C.K. Adverse Pregnancy Outcomes, Maternal Complications, and Severe Illness Among US Delivery Hospitalizations with and without a Coronavirus Disease 2019 (COVID-19) Diagnosis. Clin. Infect. Dis. 2021, 73 (Suppl. 1), S24–S31. [Google Scholar] [CrossRef]
- Zambrano, L.D.; Ellington, S.; Strid, P.; Galang, R.R.; Oduyebo, T.; Tong, V.T.; Woodworth, K.R.; Nahabedian, J.F.; Azziz-Baumgartner, E.; Gilboa, S.M.; et al. Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status—United States, January 22–3 October 2020. MMWR Morb. Mortal. Wkly. Rep. 2020, 69, 1641–1647. [Google Scholar] [CrossRef]
- Vousden, N.; Bunch, K.; Morris, E.; Simpson, N.; Gale, C.; O’Brien, P.; Quigley, M.; Brocklehurst, P.; Kurinczuk, J.J.; Knight, M. The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from March to September 2020: A national cohort study using the UK Obstetric Surveillance System (UKOSS). PLoS ONE 2021, 16, e0251123. [Google Scholar] [CrossRef]
- CDC. COVID-19 Vaccination among Pregnant People Aged 18–49 Years Overall, by Race/Ethnicity, and Date Reported to CDC—Vaccine Safety Datalink, * United States. 2022. Available online: https://covid.cdc.gov/covid-data-tracker/#vaccinations-pregnant-women (accessed on 31 August 2022).
- Riad, A.; Jouzová, A.; Üstün, B.; Lagová, E.; Hruban, L.; Janků, P.; Pokorná, A.; Klugarová, J.; Koščík, M.; Klugar, M. COVID-19 Vaccine Acceptance of Pregnant and Lactating Women (PLW) in Czechia: An Analytical Cross-Sectional Study. Int. J. Environ. Res. Public Health 2021, 18, 13373. [Google Scholar] [CrossRef]
- World Health Organization: WHO. Ten Threats to Global Health in 2019. Available online: https://www.who.int/news-room/feature-stories/ten-threats-to-global-health-in-2019 (accessed on 27 February 2021).
- MacDonald, N.E. SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: Definition, scope and determinants. Vaccine 2015, 33, 4161–4164. [Google Scholar] [CrossRef]
- Yalçin, S.S.; Kömürlüoğlu, A.; Topaç, O. Rates of childhood vaccine refusal in Turkey during 2016–2017: Regional causes and solutions. Arch. Pediatr. 2022. Epub ahead of print. [Google Scholar] [CrossRef] [PubMed]
- Uludağ, E.; Serçekuş, P.; Yıldırım, D.F.; Özkan, S. A qualitative study of pregnant women’s opinions on COVID-19 vaccines in Turkey. Midwifery 2022, 114, 103459. [Google Scholar] [CrossRef] [PubMed]
- Ekmez, M.; Ekmez, F. Assessment of factors affecting attitudes and knowledge of pregnant women about COVID-19 vaccination. J. Obstet. Gynaecol. 2022, 42, 1984–1990. [Google Scholar] [CrossRef] [PubMed]
- Kılınçarslan, M.; Sarıgül, B.; Toraman, Ç.; Şahin, E. Development of Valid and Reliable Scale of Vaccine Hesitancy in Turkish Language. Konuralp. Med. J. 2020, 12, 420–429. [Google Scholar] [CrossRef]
- Shapiro, G.K.; Tatar, O.; Dube, E.; Amsel, R.; Knauper, B.; Naz, A.; Perez, S.; Rosberger, Z. The vaccine hesitancy scale: Psychometric properties and validation. Vaccine 2018, 36, 660–667. [Google Scholar] [CrossRef]
- Citu, C.; Chiriac, V.D.; Citu, I.M.; Gorun, O.M.; Burlea, B.; Bratosin, F.; Popescu, D.-E.; Ratiu, A.; Buca, O.; Gorun, F. Appraisal of COVID-19 Vaccination Acceptance in the Romanian Pregnant Population. Vaccines 2022, 10, 952. [Google Scholar] [CrossRef]
- Regan, A.K.; Kaur, R.; Nosek, M.; Swathi, P.A.; Gu, N.Y. COVID-19 vaccine acceptance and coverage among pregnant persons in the United States. Prev. Med. Rep. 2022, 29, 101977. [Google Scholar] [CrossRef]
- Davies, D.; McDougall, A.; Prophete, A.; Sivashanmugarajan, V.; Yoong, W. COVID-19 vaccination: Patient uptake and attitudes in a multi-ethnic North London maternity unit. Postgrad. Med. J 2022. Epub ahead of print. [Google Scholar] [CrossRef]
- Huré, M.; Peyronnet, V.; Sibiude, J.; Cazenave, M.; Anselem, O.; Luton, D.; Vauloup-Fellous, C.; Deruelle, P.; Cordier, A.; Benachi, A.; et al. Acceptabilité du vaccin-Sars CoV-2 chez les femmes enceintes, une enquête transversale par questionnaire [SARS-Cov-2 vaccine’s acceptance among pregnant women-A cross-sectional survey]. Gynecol. Obstet. Fertil. Senol 2022. Epub ahead of print. [Google Scholar] [CrossRef]
- Nemat, A.; Yaftali, S.; Danishmand, T.J.; Nemat, H.; Raufi, N.; Asady, A. High rates of COVID-19 vaccine refusal among Afghan pregnant women: A cross sectional study. Sci. Rep. 2022, 12, 14057. [Google Scholar] [CrossRef]
- Gunawardhana, N.; Baecher, K.; Boutwell, A.; Pekwarake, S.; Kifem, M.; Ngong, M.G.; Fondzeyuf, A.; Halle-Ekane, G.; Mbah, R.; Tih, P.; et al. COVID-19 vaccine acceptance and perceived risk among pregnant and non-pregnant adults in Cameroon, Africa. PLoS ONE 2022, 17, e0274541. [Google Scholar] [CrossRef] [PubMed]
- Nowacka, U.; Malarkiewicz, P.; Sierdzinski, J.; Januszaniec, A.; Kozłowski, S.; Issat, T. COVID-19 Vaccination Status among Pregnant and Postpartum Women-A Cross-Sectional Study on More Than 1000 Individuals. Vaccines 2022, 10, 1179. [Google Scholar] [CrossRef] [PubMed]
- Reifferscheid, L.; Marfo, E.; Assi, A.; Dubé, E.; MacDonald, N.E.; Meyer, S.B.; Bettinger, J.A.; Driedger, S.M.; Robinson, J.; Sadarangani, M.; et al. COVID-19 vaccine uptake and intention during pregnancy in Canada. Can. J. Public Health 2022, 113, 547–558. [Google Scholar] [CrossRef]
- Barchielli, B.; Cricenti, C.; Gallè, F.; Sabella, E.A.; Liguori, F.; Da Molin, G.; Liguori, G.; Orsi, G.B.; Giannini, A.M.; Ferracuti, S.; et al. Climate Changes, Natural Resources Depletion, COVID-19 Pandemic, and Russian-Ukrainian War: What Is the Impact on Habits Change and Mental Health? Int. J. Environ. Res. Public Health 2022, 19, 11929. [Google Scholar] [CrossRef]
- Cotter, S.B.; Taylor, L.; Grace, R.; Miao, D.; Ratan, B.M. Routine Maternal Vaccine Uptake during the COVID-19 Pandemic. Am. J. Perinatol 2022. Epub ahead of print. [Google Scholar] [CrossRef] [PubMed]
- Rand, C.M.; Bender, R.; Humiston, S.G.; Albertin, C.; Olson-Chen, C.; Chen, J.; Hsu, Y.-S.J.; Vangala, S.; Szilagyi, P.G. Obstetric Provider Attitudes and Office Practices for Maternal Influenza and Tdap Vaccination. J. Womens Health 2022, 31, 1246–1254. [Google Scholar] [CrossRef]
- Dağdeviren, G.; Örgül, G.; Yücel, A.; Şahin, D. Tetanus vaccine during pregnancy: Data of a tertiary hospital in Turkey. Turk. J. Med. Sci. 2020, 50, 1903–1908. [Google Scholar] [CrossRef] [PubMed]
DEMOGRAPHICAL QUESTIONS Name surname: Age: Date of birth: Citizen number: Educational status
Yes No Questions about pregnancy Gestational week: Gravida: Number of parity: Number of living children: The ages of the living children: QUESTIONS ABOUT VACCINATION AND COVID-1 Have you had a COVID-19 infection during pregnancy? Yes No Have you had a COVID-19 infection before pregnancy? Yes No Have you received the COVID-19 vaccine during pregnancy? Yes No If your answer is no, please tick the options below that apply to you. Can you tick more than one option? These questions are to determine the cause of your vaccine hesitancy.
|
QUESTIONS ABOUT THE OTHER RECOMMENDED VACCINES Have you received the influenza vaccine during pregnancy? Yes No If your answer is no, please tick the options below that apply to you. Can you tick more than one option?
Yes No |
If your answer is no, please tick the options below that apply to you. Can you tick more than one option?
|
Educational Status | N | % |
---|---|---|
Literate | 8 | 3.2 |
Primary school graduate | 34 | 13.8 |
Secondary school graduate | 64 | 25.9 |
High school graduate | 76 | 30.8 |
Graduated from a University | 62 | 25.1 |
Postgraduate education | 3 | 1.2 |
Total number | 247 | 100 |
Working Status | N | % |
Active employee | 42 | 17 |
Not working | 205 | 83 |
Total number | 247 | 100 |
Gravida | N | % |
First | 70 | 28.3 |
Second | 87 | 35.2 |
Third | 54 | 21.9 |
Fourth and more | 36 | 14.6 |
Total number | 247 | 100 |
COVID-19 n (%) | Tetanus n (%) | Influenza n (%) | |
---|---|---|---|
Number of unvaccinated people | 154 (62.3) | 44 (17.8) | 246 (99.6) |
Reasons for vaccine refusal: | |||
a. I’m afraid of the side effects of vaccines | 77 (50.0) | 8 (18.2) | 9 (3.7) |
b. I don’t believe vaccines will prevent disease | 9 (5.8) | 2 (4.5) | 9 (3.7) |
c. I had a side effect when I was vaccinated before | 4 (2.6) | 1 (2.3) | 3 (1.2) |
d. I don’t think I’m in the risk group for this disease | 12 (7.8) | 6 (13.6) | 48 (19.5) |
e. I don’t want it for religious reasons | 3 (1.9) | 0 | 0 |
f. I don’t want it because of the news in the media | 6 (3.9) | 1 (2.3) | 2 (0.8) |
g. I did not want it because my partner did not approve | 7 (4.5) | 2 (4.5) | 1 (0.4) |
h. My physician did not find it necessary because I got vaccinated before pregnancy | 23 (14.9) | 3 (6.8) | 3 (1.2) |
i. I have not been vaccinated because I have had a COVID-19 infection in the last 3 months | 4 (2.6) | - | - |
j. I did not know that I should be vaccinated, I did not know enough about the vaccine | 5 (3.2) | 12 (27.3) | 124 (50.4) |
k. My physician did not recommend it, if he/she recommended it, I would have it got it | 7 (4.5) | 8 (18.2) | 39 (15.9) |
n (%) | n (%) | p-Value | Cramer’s V | |
---|---|---|---|---|
Age (Years) | <28.7 | ≥28.7 | ||
Tetanus vaccine | 22 (17.3) | 22 (18.3) | 0.836 | 0.013 |
Influenza vaccine | 126 (99.2) | 120 (100) | 0.999 | 0.062 |
COVID-19 vaccine | 83 (65.4) | 71 (59.2) | 0.316 | 0.064 |
Gravida | One | Two and More | ||
Tetanus vaccine | 10 (14.3) | 34 (19.2) | 0.362 | 0.058 |
Influenza vaccine | 69 (98.6) | 177 (100) | 0.283 | 0.101 |
COVID-19 vaccine | 44 (62.9) | 110 (62.1) | 0.917 | 0.007 |
Working Status | Not Working | Active Employment | ||
Tetanus vaccine | 36 (17.6) | 8 (19.0) | 0.819 | 0.015 |
Influenza vaccine | 204 (99.5) | 42 (100) | 0.999 | 0.029 |
COVID-19 vaccine | 131 (63.9) | 23 (54.8) | 0.265 | 0.071 |
Educational Status | <High School | High School or More | ||
Tetanus vaccine | 17 (16.0) | 27 (19.1) | 0.527 | 0.010 |
Influenza vaccine | 106 (100.0) | 140 (99.3) | 0.999 | 0.107 |
COVID-19 vaccine | 68 (64.2) | 86 (61.0) | 0.612 | 0.048 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Karagöz Özen, D.S.; Karagöz Kiraz, A.; Yurt, Ö.F.; Kiliç, I.Z.; Demirağ, M.D. COVID-19 Vaccination Rates and Factors Affecting Vaccine Hesitancy among Pregnant Women during the Pandemic Period in Turkey: A Single-Center Experience. Vaccines 2022, 10, 1910. https://doi.org/10.3390/vaccines10111910
Karagöz Özen DS, Karagöz Kiraz A, Yurt ÖF, Kiliç IZ, Demirağ MD. COVID-19 Vaccination Rates and Factors Affecting Vaccine Hesitancy among Pregnant Women during the Pandemic Period in Turkey: A Single-Center Experience. Vaccines. 2022; 10(11):1910. https://doi.org/10.3390/vaccines10111910
Chicago/Turabian StyleKaragöz Özen, Düriye Sila, Arzu Karagöz Kiraz, Ömer Faruk Yurt, Ilknur Zeynep Kiliç, and Mehmet Derya Demirağ. 2022. "COVID-19 Vaccination Rates and Factors Affecting Vaccine Hesitancy among Pregnant Women during the Pandemic Period in Turkey: A Single-Center Experience" Vaccines 10, no. 11: 1910. https://doi.org/10.3390/vaccines10111910
APA StyleKaragöz Özen, D. S., Karagöz Kiraz, A., Yurt, Ö. F., Kiliç, I. Z., & Demirağ, M. D. (2022). COVID-19 Vaccination Rates and Factors Affecting Vaccine Hesitancy among Pregnant Women during the Pandemic Period in Turkey: A Single-Center Experience. Vaccines, 10(11), 1910. https://doi.org/10.3390/vaccines10111910